✦ LIBER ✦

Sclerosing therapy in chronic Achilles tendon insertional pain-results of a pilot study

✍ Scribed by Lars Öhberg; Håkan Alfredson

Publisher: Springer-Verlag
Year: 2003
Tongue: English
Weight: 249 KB
Volume: 11
Category: Article
ISSN: 0942-2056
DOI: 10.1007/s00167-003-0402-7

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Sclerosing polidocanol injections in chr

Sclerosing polidocanol injections in chronic painful tennis elbow-promising results in a pilot study

✍ Eva Zeisig; Lars Öhberg; Håkan Alfredson 📂 Article 📅 2006 🏛 Springer-Verlag 🌐 English ⚖ 209 KB

Sclerosing polidocanol injections to tre

Sclerosing polidocanol injections to treat chronic painful shoulder impingement syndrome-results of a two-centre collaborative pilot study

✍ Håkan Alfredson; Herlof Harstad; Simen Haugen; Lars Öhberg 📂 Article 📅 2006 🏛 Springer-Verlag 🌐 English ⚖ 212 KB

Eccentric training in chronic painful im

Eccentric training in chronic painful impingement syndrome of the shoulder: results of a pilot study

✍ Per Jonsson; Per Wahlström; Lars Öhberg; Håkan Alfredson 📂 Article 📅 2005 🏛 Springer-Verlag 🌐 English ⚖ 271 KB

Sclerosing injections to areas of neo-va

Sclerosing injections to areas of neo-vascularisation reduce pain in chronic Achilles tendinopathy: a double-blind randomised controlled trial

✍ Håkan Alfredson; Lars Öhberg 📂 Article 📅 2005 🏛 Springer-Verlag 🌐 English ⚖ 249 KB

Micromotions of Bladder Wall in Chronic

Micromotions of Bladder Wall in Chronic Pelvic Pain (CPP): A Pilot Study

✍ P. Van Os-Bossagh; L. M. Kosterman; W. C. J. Hop; B. E. Westerhof; J. V. de Bakk 📂 Article 📅 2001 🏛 Springer 🌐 English ⚖ 141 KB

Results of intensive chemotherapy in chi

Results of intensive chemotherapy in children with juvenile chronic myelomonocytic leukemia: A pilot study

✍ de Heredia, Cristina Díaz; Ortega, Juan J.; Coll, María T.; Bastida, Pilar; Oliv 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 68 KB 👁 2 views

Background. The use of chemotherapy in juvenile chronic myelomonocytic leukemia (J-CMML) has not generally been successful. Our previous experience in 11 patients demonstrated that chemotherapy with low doses of daunorubicin or cytarabine resulted in a 90% fatal outcome and a median survival rate of